Do large pharmaceutical companies need to go back to the drawing board on matters like basic respect in their relationships with clinical sites? Kim Oliver of Sanofi Aventis thinks of it this way: “The pharmaceutical industry is under a lot of pressure to do things faster, and with less money…more...
The way Eli Lilly interprets it, investigator relationship management (IRM)—the recent trend among sponsors to cater to clinical sites in order to keep them around—involves figuring out who the best sites are, and giving them plenty of work. Because sheer numbers of projects is what makes sites happy, says Jim…more...
There’s no doubt about it. Site relationship management (SRM) has taken big pharma—and big biotech, for that matter—by storm in the last year. Where there are large, bureaucratic companies developing drugs, there are new SRM initiatives. And conferences on it now abound. But just what is SRM? Each sponsor and…more...
The acquisition of Vermont’s Green Mountain Logic by Phase Forward, for $5.3 million, is a surprising and fascinating development this week. Lab Pas CT, the flagship product at Green Mountain, is designed to manage samples and work flows in Phase I. The Lab Pas software is designed to be used…more...
In 2007, Montpelier, Vermont’s Green Mountain Logic has announced it would integrate its LabPas CT laboratory management software with no fewer than five electronic data capture vendors (ClinPhone, etrials, Omnicomm Systems, Phase Forward, and Phoenix Data Systems). To find out why Green Mountain Logic is on a roll, we rang…more...
The clinical trial management system (CTMS) is a software Cinderella in the world of research. By dint of its modesty and centrality to the smooth operation of a trial, the CTMS should be a full-fledged member of the family of tools to support industry-sponsored studies. It isn’t. Yet. In a…more...
Should a clinical trial unfold like a beloved family recipe, by rote from a time-honored template passed down through generations of trial operations managers? That is one approach in the industry. Or should the process be dynamic and interactive, driven by actual and simulated data? That’s the modus operandi of…more...
In an industry with so many seasoned people, why do so few trials finish on time and at budget? If we can send people into space, shouldn’t we know what it will cost to study a new antibiotic? ClearTrial may be able to bring some modern managerial brio to the…more...
A while back, we wrote about the need to rethink the seat-of-the-pants school of managing drug supplies in this article. Since then, Tourtellotte Consulting has partnered to integrate its application with the interactive voice response system (IVRS) from the Perceptive Informatics division of Parexel. The idea? To make sure the…more...
Husbanding drug supply as judiciously as possible is a no brainer. Often as not, even experienced trial managers throw a few numbers and assumptions into an Excel spreadsheet—and hope for the best. But what about customs? Where are your depots? Is there a central randomization of patients? What is the…more...
December 3, 2008
In the third part of our series, a softer approach to win the hearts of clinician-investigators.
In the second segment of our series on investigator relationship management, Lilly discusses plans to zero in on high-performing sites.
Sponsors are abuzz about site relationship management (SRM). In the first installment of our series, Wyeth describes its efforts to become the sponsor of choice.
Why Phase Forward bought Green Mountain Logic, a specialist in Phase I and management of laboratory samples and data.
Green Mountain Logic is prospering by helping Phase I clinical sites with labs, scheduling and recruitment. Some predictions about the CRO industry usage of the software.
Some customers invest in a clinical trial management system for better visibility into a trial. Others like owning their data for future projects.
Organizations
Conferences
Info & Opinion
